🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Get to know MASH: liverinstitute.medschool.vcu.edu/news/understan…

Thank Richard Sterling for FIB-4!

Today, the LATAM Consensus on Hepatic Encephalopathy was presented ALEH and Mario Pessoa represented us #EASLcongress 2025 Thanks for the space. A great discussion panel, look forward to its publication soon. Debbie Shawcross Jasmohan Bajaj FATIMA Higuera VELARDEMD

Institute Director Dr. Arun Sanyal discusses the ESENCE clinical trial, in which a weekly dose of #semaglutide was shown to be effective at treating fatty liver disease. #livertwitter #MASH #Ozempic fxn.ws/43piHmH

Join us May 21, 5 p.m. EDT, to hear from Michael Trauner, M.D., of the Medical University of Vienna. "Leveraging bile acid signaling to target inflammation in the gut-liver axis and beyond." #livertwitter bit.ly/4k9TSSp

📰 Diabetes and weight loss drug semaglutide may also treat liver disease📰 ⁠ A recent study explored how semaglutide impacted outcomes for people with metabolic dysfunction-associated steatohepatitis (type of liver disease). VCU Stravitz-Sanyal Institute for Liver Disease School of Immunology & Microbial Sciences

Join us at noon, May 28, for a presentation by Luis Antonio DÍaz Piga, M.D., of UC San Diego, on “MetALD: Bridging the Gap Between Metabolic Dysfunction and Alcohol-Associated Liver Disease.” Register at bit.ly/3GKSB5O #livertwitter

Join us May 21, 5 p.m. EDT, to hear from Michael Trauner, M.D., of the Medical University of Vienna. "Leveraging bile acid signaling to target inflammation in the gut-liver axis and beyond." #livertwitter bit.ly/4k9TSSp

Our Wednesday seminar speaker, Luis Antonio Díaz, MD!

Our Juan Pablo (JP) Arab, MD !

Join us May 21, 5 p.m. EDT, to hear from Michael Trauner, M.D., of the Medical University of Vienna. "Leveraging bile acid signaling to target inflammation in the gut-liver axis and beyond." #livertwitter bit.ly/4k9TSSp

Striking slide shared by Dr Trauner VCU Stravitz-Sanyal Institute for Liver Disease Grand Rounds From 10,000 molecules to 1 approved drug-a reminder that persistence fuels every breakthrough in science 🧬 Power on 💪 Saul Karpen Arun J. Sanyal AASLD EASLnews EASL Education Liver Fellow Network

Appreciate my colleague Jasmohan Bajaj's expertise on this topic as we seek to improve treatment for liver patients with HR.

Want to learn what's happening at the institute? Check out our May newsletter, where you can subscribe to our newsletter, and notices about upcoming events and recruitment. bit.ly/45ghDUr #livertwitter

Join us May 28 for a presentation by Luis Antonio Díaz, MD, of UC San Diego, on “MetALD: Bridging the Gap Between Metabolic Dysfunction and Alcohol-Associated Liver Disease.” Register at bit.ly/3GKSB5O #livertwitter

Join us May 28 for a presentation by Luis Antonio Díaz, MD, of UC San Diego, on “MetALD: Bridging the Gap Between Metabolic Dysfunction and Alcohol-Associated Liver Disease.” Register at bit.ly/3GKSB5O #livertwitter

"Chile of the North" has a nice ring to it ...😉

An important step forward in caring for patients with diabetes. Arun J. Sanyal